Life Sciences Hub Wales

The Electronic Prescription Service (EPS) is transforming how prescriptions are managed in Wales. EPS means prescriptions can be sent electronically, directly from a GP to a pharmacy. 

A pharmacist
  • Five million items have already been dispensed using EPS.
  • More than 50% of pharmacies in Wales are using the service, with roll out continuing as quickly and safely as possible.
  • EPS is supported by the Community Pharmacy System Innovation Fund (CPSIF), an innovative grant funding model established by Life Sciences Hub Wales and Digital Medicines on behalf of Welsh Government. 

EPS is the digital signing and managing of patient prescriptions. Instead of using a paper form, EPS means a GP or other prescriber can send a prescription directly to the pharmacy or dispensing appliance contractor (DAC) nominated by the patient electronically. 

About the project 

EPS is one of the biggest changes in decades to the way NHS Wales manages prescriptions.  

It is a key part of Digital Medicines Programmes managed by Digital Health and Care Wales (DHCW). DHCW is using digital tools to make the prescribing, dispensing and administration of medicines in Wales easier, safer, more efficient and more effective. 

Implementing electronic prescriptions is part of this digital transformation, and community pharmacy system suppliers are a vital part of making sure Wales is ready for EPS.  

The development of EPS is supported by the Community Pharmacy System Innovation Fund (CPSIF), which was established by Life Sciences Hub Wales and Digital Medicine Programmes on behalf of Welsh Government. 

CPSIF provides financial support to community pharmacy system suppliers through grant funding. A structured funding model ensures suppliers have the necessary resources to deliver solutions aligned with EPS roll out. 

Laurence James, Head of Medicines Programmes at DHCW, said:  

“The Digital Medicines programme is incredibly exciting. Everyone can see the value of it, not just for patients but for healthcare professionals too. Our biggest challenge is not persuading people that it's a good idea, but actually meeting demand and at pace. It is a privilege to be part of something that will transform the way the medicines are managed within healthcare.” 

How does it work? 

EPS is free and secure, and patients do not need to go online to use the service. They simply ask staff at their GP practice or usual pharmacy to sign them up. 

There’s no need for the traditional green paper form to be printed and collected from the surgery. It is sent electronically directly to the dispenser of the patient’s choice. 

A key benefit of a digital system is the resulting audit trail. If patients do not know the status of their prescription, they will often call their GP practice or their usual community pharmacy. Staff will then spend time investigating, often needing to call the other site to check where the prescription is. EPS means there is a quick way to track prescriptions, saving everyone time. 

Benefits 

The introduction of EPS in Wales represents a significant step forward in the digital transformation of healthcare services. It is improving the safety, efficiency and convenience of prescribing processes for healthcare professionals and patients. 

There are numerous benefits, which are already being seen by clinicians and patients. For example, GP practices report spending less time searching for prescriptions because it is easy to see the status of a prescription in the system. Other feedback from pharmacies and GPs includes ‘EPS is game-changing’ and ‘It’s the best thing we’ve ever done!’ Many of the benefits are around saving time – for patients, prescribers, pharmacy staff and GP staff. EPS also reduces the amount of printing needed, which has financial and environmental benefits. 

Jenny Pugh-Jones, Programme Oversight Chair for EPS in Wales, said:  

“Working with a range of organisations on this project has been a really positive experience. EPS brings benefits to patients, prescribers, community pharmacies and other dispensers. At the end of the day, we’re all trying to improve things for patients and for the service overall, so healthcare professionals can have more time with patients.” 

Impact for patients

EPS makes the prescribing process easier, safer and more convenient for patients. It means they do not have to go to their GP surgery just to pick up a prescription form.  

Patients also do not need to have access to a computer or smartphone to use EPS. They can tell staff at their GP or pharmacy that they wish to use EPS, and staff can do the rest. 

Impact for health professionals

EPS makes the prescribing process more efficient for healthcare staff. It eliminates the risk of a prescription getting lost, as staff can track where it is at all times.

Ultimately, the time saved by healthcare professionals on administrative processes around prescriptions should result in more time for patient care. 

System impact

Monitoring plans are in place for the 2025/26 financial year, and the expectation is that there will be positive impacts on processes across the system, saving time for patients, GPs and pharmacies.

DHCW is also working on delivering a shared medicines and allergies record for every patient in Wales, for which EPS will be an important building block. Having prescription data available digitally also facilitates data analysis, which supports work to improve the nation's health.

Tracey Robertson, Product and Technology Director for Cegedim Rx, said:

“As pharmacies face increased pressure to dispense ever greater numbers of prescription items and patient demand grows, digitising more of the prescription journey is vital. The benefits of this programme go beyond supporting pharmacy and GP practice teams and enabling them to improve efficiencies, it also ensures patients are more easily and conveniently able to access the care they need.” 

How Life Sciences Hub Wales has supported the programme 

EPS has been supported by the Community Pharmacy System Innovation Fund (CPSIF), which was established by Life Sciences Hub Wales and the Digital Medicines Programme on behalf of Welsh Government. 

CPSIF was created to support the widespread adoption of EPS across community pharmacies through grant funding, playing a pivotal role in enabling system suppliers to become EPS compliant and sending a clear message that NHS Wales wanted to work with suppliers. 

The fund was designed to cover the development work required to implement EPS (Tier 1), support innovations towards paperless pharmacy processes (Tier 2), and facilitate integration with the NHS Wales App (Tier 3). 

Life Sciences Hub Wales and DHCW have worked closely on this important programme, ensuring the grant management processes are robust and auditable. 

Laurence James, Head of Medicines Programmes at DHCW, said: 

“The Community Pharmacy System Innovation Fund has been a central component of this programme and has brought in the suppliers. Working with Life Sciences Hub Wales has been extremely positive. We wouldn’t be where we are today without that close working relationship with them.” 

As grant administrators, Life Sciences Hub Wales follows a structured and transparent process for assessing, awarding, and managing grant funding to ensure compliance and fairness. Applications are reviewed by an independent panel to determine eligibility and Grant Agreements outline project milestones, ensuring accountability and transparency. 

Sarah Clee, Grant Funding Specialist, Life Sciences Hub Wales, said:  

“I'm proud of the work we've done on CPSIF. We had an excellent internal audit result, showing that we have the systems in place to manage public funds. But the real success stories are in what DHCW and the suppliers have done to get us to this point.” 

Cari-Anne Quinn, Chief Executive Officer, Life Sciences Hub Wales, said: 

“At Life Sciences Hub Wales, we’re proud to have worked alongside Digital Health and Care Wales and software suppliers to manage the grant effectively, ensuring funding reaches recipients to continue their invaluable work.” 

What next? 

In the initial phase, community pharmacy suppliers went through a process of testing and assurance. Now in an implementation phase, the project is focussed on rolling out EPS. 

Funding for Tiers 2 and 3 has been extended for a further year (2025), during which time suppliers will work on further innovation by enhancing sustainability and user convenience. This involves implementing a paperless process to reduce the amount of paper printed in pharmacies and working on integration with the NHS Wales App to allow for push notifications to advise patients when their prescriptions are ready for collection. 

DHCW is also exploring other opportunities to use EPS, such as in urgent and emergency care settings and hospital outpatient settings. 

How can we help? 

We’re here to help drive system-wide transformation! If you want to access support similar to that outlined in this case study, we want to hear from you. 

Submit your enquiry today via our website here.